Clinical Trial Update: Oxytocin Infusions and Blood Loss in Patients Undergoing Elective Cesarean Delivery. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial updated results on the use of oxytocin infusions to manage blood loss in women undergoing elective cesarean delivery; results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: Stanford University | Conditions: Postpartum Hemorrhage | Phase 3 | Status: COMPLETED | Results posted: 2017-02-01